Using a measure of the hormone N-terminal brain natriuretic peptide (BNP) to guide therapy for older patients with heart failure did not improve overall clinical or quality of life outcomes compared ...
First results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) show that testing for brain natriuretic peptide (BNP) when evaluating congestive heart failure (CHF) patients ...
The BNP and NTproBNP market growth is driven by rising cardiovascular diseases and an aging population. Opportunities lie in ...
B-type natriuretic peptide (BNP) as well as its N-terminal fragment (NT-proBNP) can provide useful diagnostic and prognostic information in patients with acute dyspnea and chronic heart failure.
SAN DIEGO -- In a trial of nearly 1,600 patients in the United States and Europe, a 15-minute blood test enabled emergency-room doctors to correctly diagnose congestive heart failure in 9 out of 10 ...
BACKGROUND: The use of brain natriuretic peptide (BNP) in the evaluation of the dyspneic pediatric patient is increasingly supported for infants and newborns with congenital heart disease. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results